Market Currents
Cytokinetics (CYTK) says it's received notice from The Nasdaq Stock Market confirming that for...
-
Friday, January 25, 4:11 PM ETCytokinetics (CYTK) says it's received notice from The Nasdaq Stock Market confirming that for the last 10 consecutive business days, the closing bid price of its stock has been at $1.00 per share or greater, therby regained compliance with listing rules.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
